(untitled)

Pancreatic cancer (PC) is one of the most aggressive and challenging cancers to treat, accounting for a significant proportion of cancer-related deaths worldwide (Yang et al., 2024). With a five-year survival rate of just 13%, largely due to late diagnoses and resistance to conventional treatments, pancreatic cancer remains a formidable opponent in the fight against cancer (National Cancer…